CoagulationDisorders near Lafayette, CO

Biography: Dr. David Longcope grew up in Worcester, Massachusetts. He graduated Cum Laude from Colby College in Waterville, Maine where he majored in Chemistry. He performed his medical school training at the University of Vermont College of Medicine. Dr. Longcope completed his 5 years of general surgery training at the State University of New York in Syracuse. He then went on to do an additional year of fellowship training in Colon and Rectal Surgery at The Mayo Clinic in Minnesota. Dr. Longcope was in practice for 6 years in New Orleans as a colon and rectal surgeon and was an Assistant Clinical Professor of Surgery at Tulane University.He was forced to permanently move his practice to Colorado after hurricane Katrina in 2005 and joined Dr. Sgambati. Dr. Longcope specializes in laparoscopic surgery and instructs surgeons across the country on performing this advanced technique. He also has a special interest in anorectal disease and surgery for inflammatory bowel disease (Crohns and Ulcerative Colitis), diverticulitis, and colorectal cancer.Dr. Longcope is married and his interests include woodworking, hiking, biking, skiing, and running and he has finished the Leadville Trail 100 twice.

Biography: Dr. Christopher Jones, MD is an Oncology Specialist who practices in Thornton, CO. He is 53 years old and has been practicing for 28 years. Dr. Christopher Jones, MD is affiliated with HCA HealthONE Mountain Ridge.

Care Philosophy: I enjoy working with new patients and getting to know them and their families. Patients are faced with many difficult decisions, so I try to guide them in assessing their treatment options.

Care Philosophy: When I was little, my dad (who is a physician) took my brother and I on hospital rounds. I think based on that experience -at the ripe age of 6- I announced to my parents that I was going to be a doctor. Throughout high school and undergrad, he took me to the local Tumor Board meeting. I thought the entire aspect of oncology was fascinating but wasn't sure I would be able to support patients with potential for such intense grief and loss. I then chose a medical oncologist as my clinical preceptor during the first two years of medical school. I fell in love with the patients and the relationship he the oncologist was able to develop with the patient and their families.Once I was in internal medicine residency at Banner Good Samaritan Hospital in Phoenix, I was able to rotate on the BMT service and again things clicked. I was a matched for fellowship in Denver and decided to enjoy seasons as well as the fantastic life Colorado has to offer. As a physician specializing in blood cancers and blood/marrow transplant, I have the opportunity to offer patients potential cures from their cancer or live with their disease and not die from it. I love participating in research, but being with patients is what drives me. I'm so fortunate to have found CBCI where I can do both. I've been on both sides of cancer as my mother passed from acute leukemia and I strive to be the doctor she and my family needed blending medical expertise and matching that with patient goals and quality of life.I believe that patients place an amazing amount of trust in their oncologist to guide them through their treatments. My goal is to earn that trust being not only a doctor, but a teacher as well. I work to ensure my patients understand their disease and treatments. I strive to ensure I understand a patient's goals and fears and help guide treatment decisions that honor those values.

Care Philosophy: Dr. Matous' practice philosophy is that it is an honor and privilege to care for patients with blood cancers, and to make available to them the most up to date, innovated and appropriate treatment while respecting their individuality and dignity.

Biography: Henning Schade, MD is an Assistant Member Physician at the Colorado Blood Cancer Institute and part of the Plasma Cell and Lymphoid Disease Groups. Dr. Schade completed his Bone Marrow Transplant Fellowship Program at CBCI in 2017 and joined immediately afterward. Dr. Schade is board certified in Internal Medicine and Oncology and has focused his training in Bone Marrow Transplantation and Malignant Hematology.Dr. Schade was born and raised in Hesse, Germany. He stayed in his hometown near Frankfurt/Main until completion of high school when he decided to join a Catholic church group for a mandatory civilian service. Henning has been dedicated to patient care since he started working with patients and elderly with special needs during this period of civilian service. This inspired him to join nursing school for a 3-year training to become licensed nurse.Soon after he finished nursing school in 1998, he signed up for medical school training. He continued to work as a part-time nurse during this time. After finishing med school in 2006 he joined UK-S-H in Kiel, Germany to initiate training as an internal medicine resident and BMT trainee at the bone marrow transplantation center at MSH Kiel. He stayed there until 2010 when he decided to move to the US to continue training as a physician. Dr. Schade then finished a residency in internal medicine in 2014 at MUSC in Charleston South Carolina. He then joined University of Colorado/Anschutz for a Hematology/Oncology Fellowship. After completion in 2016, he joined Colorado Blood Cancer Institute for dedicated BMT fellowship year.Dr. Schade has published several scientific articles, abstracts and posters at ASCO, ASH and EBMT, including his doctoral thesis about second allogeneic stem cell transplantation in patients with relapsed hematologic malignancy. During his time as an internal medicine resident at MUSC he worked in Dr. Yubin Kang™s lab on Multiple Myeloma cell lines and became interested in translational research. During his fellowship in Hematology/Oncology at the University of Colorado he worked in Brent Palmer's lab and studied PD-1 expression on CD4+ T cells and CMV+ T cells after allogenic stem cell transplantation. The results were published in BBMT in 08/2016. These findings were the fundamental basis for his upcoming research projects.Dr. Schade's research interest is primarily in the treatment of plasma cell and lymphoid diseases. He is the primary investigator for several clinical studies that investigate novel treatment options for patients with Multiple Myeloma and Hodgkin lymphoma. He also has a strong research interest in immune reconstitution after autologous and allogenic stem cell transplantation and has published his research in journals such as BBMT. At The Colorado Blood Cancer Institute he developed an investigator initiated a phase 1 protocol for patients with chemotherapy-refractory AML/MDS using GVHD prophylaxis with posttransplant cyclophosphamide followed by PD-1 inhibition with Nivolumab for consolidation. This protocol now offers a potentially curative treatment option for patients that otherwise would not meet criteria to undergo allogenic stem cell transplantation.Dr. Schade loves to bake all kinds of goodies including sourdough bread, bagels and New York style pizza. He also loves to go fishing with his kids. He loves the outdoors and can be found in the mountains hiking and skiing with his family. Dr. Schade is an enthusiastic fan of the Denver Nuggets and he of course is a big fan of European soccer.

Care Philosophy: I believe in the human element of medicine. Patients deserve a partner in care. To that end, I am dedicated to open communication with each patient so that together we can establish a relationship built on trust and work together toward the best outcome possible.

Care Philosophy: I have experienced cancer firsthandfirst, as a teen when my father was diagnosed with pancreatic cancer. Shortly after, I was diagnosed with acute leukemia. These experiences are what brought me to this career and are what drive my passion for treating my patients. It also gives me unique insight into and empathy for what my patients and their families are experiencing, which adds an additional layer to my care.